These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 207776)

  • 1. Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen.
    Sakamoto K; Hinuma Y
    J Immunol; 1978 May; 120(5):1702-8. PubMed ID: 207776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus.
    Hinuma Y; Sakamoto K
    IARC Sci Publ (1971); 1978; (24 Pt 1):249-51. PubMed ID: 87368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K; Harada M; Sairenji T; Hinuma Y
    J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T; Mizuno F; Osato T
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
    Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
    J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of Paul-Bunnell type heterophile antibody in sera from infectious mononucleosis patients with the surface of lymphoid cells carrying Epstein-Barr virus genomes.
    Maeda M; Sairenji T; Hinuma Y
    Microbiol Immunol; 1979; 23(12):1189-97. PubMed ID: 231730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
    Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
    J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
    Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T
    Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
    Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
    J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of mitogens on the expression of Epstein-Barr virus antigens in human lymphoid cell lines.
    Tovey MG; Lenoir G; Begon-Lours J; Tapiero H; Rochette-Egly C
    J Immunol; 1979 Jul; 123(1):138-42. PubMed ID: 221589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human B cell line deficient in the expression of B cell-specific glycoproteins (GP 27,35).
    Trowbridge IS; Hyman R; Klein G
    Eur J Immunol; 1977 Sep; 7(9):640-5. PubMed ID: 72671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis.
    Hutt LM; Huang YT; Dascomb HE; Pagano JS
    J Immunol; 1975 Jul; 115(1):243-8. PubMed ID: 168255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.
    Franklin SM; North JR; Morgan AJ; Epstein MA
    J Gen Virol; 1981 Apr; 53(Pt 2):371-6. PubMed ID: 6167667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
    Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
    J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.